Showing results (1141-1150 of 3,790) with videos related to
Sort By:
Pageof 379
Oncoimmunology|February 7, 2014
Dendritic cell-based immunotherapy in ovarian cancerAn Coosemans, Ignace Vergote, Stefaan W Van GoolOncoimmunology|February 7, 2014
Alerting the immune system via stromal cells is central to the prevention of tumor growthShohreh Issazadeh-NavikasOncoimmunology|February 7, 2014
Finding a needle in a haystack: Activation-induced CD137 expression accurately identifies naturally occurring tumor-reactive T cells in cancer patientsQunrui Ye, De-Gang Song, Daniel J PowellOncoimmunology|February 25, 2014
High-affinity peptide-based anticancer vaccination to overcome resistance to immunostimulatory antibodiesDavid C Binder, Hans SchreiberOncoimmunology|October 17, 2022
RHOA G17V induces T follicular helper cell specification and involves angioimmunoblastic T-cell lymphoma via upregulating the expression of PON2 through an NF-κB-dependent mechanismFenglian Que, Lihong Zhang, Taoli Wang, et al.Oncoimmunology|June 28, 2012
Development of immune memory to glial brain tumors after tumor regression induced by immunotherapeutic Toll-like receptor 7/8 activationApostolis Stathopoulos, Chrystel Pretto, Laurent Devillers, et al.Oncoimmunology|June 28, 2012
The immuno-oncology framework: Enabling a new era of cancer therapyAxel Hoos, Cedrik BrittenOncoimmunology|June 28, 2012
Activation of antigen-exposed iMC-DCs at the "right place" and "right time" promotes potent anti-tumor immunityDavid M SpencerOncoimmunology|June 28, 2012
Are the immuno-stimulatory properties of Lenalidomide extinguished by co-administration of Dexamethasone?Andy Hsu, David S Ritchie, Paul NeesonOncoimmunology|June 28, 2012
The combination of histone deacetylase inhibitors with immune-stimulating antibodies has potent anti-cancer effectsAlison C West, Ailsa J Christiansen, Mark J Smyth, et al.Pageof 379